Diagnosis and Management of Anaplastic Thyroid Cancer
- PMID: 30717908
- DOI: 10.1016/j.ecl.2018.10.010
Diagnosis and Management of Anaplastic Thyroid Cancer
Abstract
Anaplastic thyroid cancer (ATC) is a devastating and usually incurable diagnosis. Clinical and pathologic diagnosis is best assessed at a tertiary center with concentrated ATC expertise. Expeditious multidisciplinary management is recommended for optimal patient outcomes. Based on multiinstitutional and population-based studies, multimodal therapy that includes chemoradiotherapy with surgery (when feasible) is the preferred initial treatment because it is associated with incrementally improved overall survival. In ATC that carries a BRAF V600E somatic mutation, combination therapy with BRAF and MEK inhibitors has shown promise but needs further study. Immunotherapeutic agents in neoadjuvant and metastatic settings are being investigated.
Keywords: Anaplastic thyroid cancer; Chemoradiotherapy; Multimodality therapy; Systemic therapy.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
